Knee Injuries
📧 Sign up to get email alerts when something new happens for Knee Injuries.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2026-04-15EMA Application withdrawn: Jelrix — TETEC Tissue Engineering Technologies AG
EMA has withdrawn the Jelrix application from TETEC Tissue Engineering Technologies AG. The product targeted knee injuries and cartilage dis…
-
CLINICAL_TRIALS withdrawal · 2024-11-25Clinical Trial Update: Effects of Blood Flow Restriction (BFR) Therapy on ACL Graft Maturation [NA]
A clinical trial evaluating blood flow restriction therapy for ACL graft maturation was withdrawn, with no further study details available.
-
CLINICAL_TRIALS withdrawal · 2024-05-24Clinical Trial Update: Dynamic Contrast-Enhanced Fluorescence Arthroscopy of Meniscus Pilot [NA]
A pilot study evaluating dynamic contrast-enhanced fluorescence arthroscopy for meniscal knee injuries has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-06-11Clinical Trial Update: Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee Arhroscopy [Phase 4]
A Phase 4 clinical trial investigating intraarticular IL-1 receptor antagonist for pain and inflammatory mediators after knee arthroscopy ha…
-
CLINICAL_TRIALS withdrawal · 2021-04-20Clinical Trial Update: Effect of Loading of Midazolam or Dexmedetomidine on Hemodynamics [Phase 4]
A Phase 4 clinical trial investigating the effect of loading midazolam or dexmedetomidine on hemodynamics has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.